The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
Envelope glycans of immunodeficiency virions are almost entirely oligomannose antigens
Open accessAbstract
The envelope spike of HIV is one of the most highly N-glycosylated structures found in nature. However, despite extensive research revealing essential functional roles in infection and immune evasion, the chemical structures of the glycans on the native viral envelope glycoprotein gp120—as opposed to recombinantly generated gp120—have not been described. Here, we report on the identity of the N-linked glycans from primary isolates of HIV-1 (clades A, B, and C) and from the simian immunodeficiency virus. MS analysis reveals a remarkably simple and highly conserved virus-specific glycan profile almost entirely devoid of medial Golgi-mediated processing. In stark contrast to recombinant gp120, which shows extensive exposure to cellular glycosylation enzymes (>70% complex type glycans), the native envelope shows barely detectable processing beyond the biosynthetic intermediate Man 5 GlcNAc 2 (<2% complex type glycans). This oligomannose (Man 5–9 GlcNAc 2 ) profile is conserved across primary isolates and geographically divergent clades but is not reflected in the current generation of gp120 antigens used for vaccine trials. In the context of vaccine design, we also note that Manα1→2Man-terminating glycans (Man 6–9 GlcNAc 2 ) of the type recognized by the broadly neutralizing anti-HIV antibody 2G12 are 3-fold more abundant on the native envelope than on the recombinant monomer and are also found on isolates not neutralized by 2G12. The Manα1→2Man residues of gp120 therefore provide a vaccine target that is physically larger and antigenically more conserved than the 2G12 epitope itself. This study revises and extends our understanding of the glycan shield of HIV with implications for AIDS vaccine design.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
ASSEMBLY OF ASPARAGINE-LINKED OLIGOSACCHARIDES
Kornfeld, R., & Kornfeld, S. (1985) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.54.070185.003215 · Cited by 4,906
Wiederschain, G. Y. (2009) · Biochemistry (Moscow) · doi:10.1134/s0006297909090156 · Cited by 4,083
Vaccination with ALVAC and AIDSVAX to Prevent HIV-1 Infection in Thailand
Rerks-Ngarm, S., Pitisuttithum, P., Nitayaphan, S., Kaewkungwal, J., Chiu, J., Paris, R., Premsri, N., Namwat, C., de Souza, M., Adams, E., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0908492 · Cited by 3,034
DC-SIGN, a dendritic cell-specific HIV-1-binding protein that enhances trans-infection of T cells
Geijtenbeek, T. B. H., Kwon, D. S., Torensma, R., van Vliet, S. J., van Duijnhoven, G. C. F., Middel, J., Cornelissen, I. L. M. H. A., Nottet, H. S. L. M., KewalRamani, V. N., Littman, D. R., et al. (2000) · Cell · doi:10.1016/s0092-8674(00)80694-7 · Cited by 2,447
Antibody neutralization and escape by HIV-1
Wei, X., Decker, J. M., Wang, S., Hui, H., Kappes, J. C., Wu, X., Salazar-Gonzalez, J. F., Salazar, M. G., Kilby, J. M., Saag, M. S., et al. (2003) · Nature · doi:10.1038/nature01470 · Cited by 2,421
Varki, A. P., Cummings, R. D., Esko, J. D., Freeze, H. H., Stanley, P., Bertozzi, C. R., Hart, G. W., & Etzler, M. E. (1999) · Cited by 2,384
Broad and Potent Neutralizing Antibodies from an African Donor Reveal a New HIV-1 Vaccine Target
Walker, L. M., Phogat, S. K., Chan-Hui, P.-Y., Wagner, D., Phung, P., Goss, J. L., Wrin, T., Simek, M. D., Fling, S., Mitcham, J. L., et al. (2009) · Science · doi:10.1126/science.1178746 · Cited by 1,723
Self-citationThe Impact of Glycosylation on the Biological Function and Structure of Human Immunoglobulins
Arnold, J. N., Wormald, M. R., Sim, R. B., Rudd, P. M., & Dwek, R. A. (2007) · Annual Review of Immunology · doi:10.1146/annurev.immunol.25.022106.141702 · Cited by 1,307
Self-citationLi, M., Gao, F., Mascola, J. R., Stamatatos, L., Polonis, V. R., Koutsoukos, M., Voss, G., Goepfert, P., Gilbert, P., Greene, K. M., et al. (2005) · Journal of Virology · doi:10.1128/jvi.79.16.10108-10125.2005 · Cited by 1,070
A time- and cost-efficient system for high-level protein production in mammalian cells
Aricescu, A. R., Lu, W., & Jones, E. Y. (2006) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444906029799 · Cited by 762
Scanlan, C. N., Pantophlet, R., Wormald, M. R., Saphire, E. O., Stanfield, R., Wilson, I. A., Katinger, H., Dwek, R. A., Rudd, P. M., & Burton, D. R. (2002) · Journal of Virology · doi:10.1128/jvi.76.14.7306-7321.2002 · Cited by 665
Self-citationReeves, P. J., Callewaert, N., Contreras, R., & Khorana, H. G. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.212519299 · Cited by 640
Sanders, R. W., Venturi, M., Schiffner, L., Kalyanaraman, R., Katinger, H., Lloyd, K. O., Kwong, P. D., & Moore, J. P. (2002) · Journal of Virology · doi:10.1128/jvi.76.14.7293-7305.2002 · Cited by 553
GP120: Target for Neutralizing HIV-1 Antibodies
Pantophlet, R., & Burton, D. R. (2006) · Annual Review of Immunology · doi:10.1146/annurev.immunol.24.021605.090557 · Cited by 445
Self-citationNeutralizing antibodies generated during natural HIV-1 infection: good news for an HIV-1 vaccine?
Stamatatos, L., Morris, L., Burton, D. R., & Mascola, J. R. (2009) · Nature Medicine · doi:10.1038/nm.1949 · Cited by 430
Self-citationKüster, B., Wheeler, S. F., Hunter, A. P., Dwek, R. A., & Harvey, D. J. (1997) · Analytical Biochemistry · doi:10.1006/abio.1997.2199 · Cited by 358
Self-citationPancera, M., Majeed, S., Ban, Y.-E. A., Chen, L., Huang, C.-C., Kong, L., Kwon, Y. D., Stuckey, J., Zhou, T., Robinson, J. E., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0911004107 · Cited by 338
Structural Basis of Immune Evasion at the Site of CD4 Attachment on HIV-1 gp120
Chen, L., Do Kwon, Y., Zhou, T., Wu, X., O’Dell, S., Cavacini, L., Hessell, A. J., Pancera, M., Tang, M., Xu, L., et al. (2009) · Science · doi:10.1126/science.1175868 · Cited by 300
Self-citationWang, S.-K., Liang, P.-H., Astronomo, R. D., Hsu, T.-L., Hsieh, S.-L., Burton, D. R., & Wong, C.-H. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0712326105 · Cited by 287
Self-citationSpecificity of DC‐SIGN for mannose‐ and fucose‐containing glycans
van Liempt, E., Bank, C. M. C., Mehta, P., Garcı´a-Vallejo, J. J., Kawar, Z. S., Geyer, R., Alvarez, R. A., Cummings, R. D., Kooyk, Y. V., & van Die, I. (2006) · FEBS Letters · doi:10.1016/j.febslet.2006.10.009 · Cited by 286
Harvey, D. J., Merry, A. H., Royle, L., P. Campbell, M., Dwek, R. A., & Rudd, P. M. (2009) · PROTEOMICS · doi:10.1002/pmic.200900096 · Cited by 267
Self-citationExploiting the defensive sugars of HIV-1 for drug and vaccine design
Scanlan, C. N., Offer, J., Zitzmann, N., & Dwek, R. A. (2007) · Nature · doi:10.1038/nature05818 · Cited by 250
Self-citationMcMichael, A. J. (2006) · Annual Review of Immunology · doi:10.1146/annurev.immunol.24.021605.090605 · Cited by 246
Balzarini, J., Schols, D., Neyts, J., Van Damme, E., Peumans, W., & De Clercq, E. (1991) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.35.3.410 · Cited by 231
Mass Spectrometric Characterization of the Glycosylation Pattern of HIV-gp120 Expressed in CHO Cells
Zhu, X., Borchers, C., Bienstock, R. J., & Tomer, K. B. (2000) · Biochemistry · doi:10.1021/bi000432m · Cited by 222
Mizuochi, T., Spellman, M. W., Larkin, M., Solomon, J., Basa, L. J., & Feizi, T. (1988) · Biochemical Journal · doi:10.1042/bj2540599 · Cited by 201
Harvey, D. J., Royle, L., Radcliffe, C. M., Rudd, P. M., & Dwek, R. A. (2008) · Analytical Biochemistry · doi:10.1016/j.ab.2008.01.025 · Cited by 192
Self-citationLi, Y., Cleveland, B., Klots, I., Travis, B., Richardson, B. A., Anderson, D., Montefiori, D., Polacino, P., & Hu, S.-L. (2008) · Journal of Virology · doi:10.1128/jvi.01691-07 · Cited by 164
Lee, H., Scanlan, C. N., Huang, C., Chang, A. Y., Calarese, D. A., Dwek, R. A., Rudd, P. M., Burton, D. R., Wilson, I. A., & Wong, C. (2004) · Angewandte Chemie International Edition · doi:10.1002/anie.200353105 · Cited by 131
Self-citationWang, L., Ni, J., Singh, S., & Li, H. (2004) · Chemistry & Biology · doi:10.1016/j.chembiol.2003.12.020 · Cited by 125
Fully Synthetic Carbohydrate HIV Antigens Designed on the Logic of the 2G12 Antibody
Krauss, I. J., Joyce, J. G., Finnefrock, A. C., Song, H. C., Dudkin, V., Geng, X., Warren, J. D., Chastain, M. A., Shiver, J. W., & Danishefsky, S. J. (2007) · Journal of the American Chemical Society · doi:10.1021/ja074804r · Cited by 124
Fischer, P. B., Karlsson, G. B., Butters, T. D., Dwek, R. A., & Platt, F. M. (1996) · Journal of Virology · doi:10.1128/jvi.70.10.7143-7152.1996 · Cited by 115
Self-citationGlycosylation Site-Specific Analysis of Clade C HIV-1 Envelope Proteins
Go, E. P., Chang, Q., Liao, H., Sutherland, L. L., Alam, S. M., Haynes, B. F., & Desaire, H. (2009) · Journal of Proteome Research · doi:10.1021/pr9002728 · Cited by 95
Quantification of infectious HIV-1 plasma viral load using a boosted in vitro infection protocol
Rusert, P., Fischer, M., Joos, B., Leemann, C., Kuster, H., Flepp, M., Bonhoeffer, S., Günthard, H. F., & Trkola, A. (2004) · Virology · doi:10.1016/j.virol.2004.05.022 · Cited by 91
Dunlop, D. C., Bonomelli, C., Mansab, F., Vasiljević, S., Doores, K. J., Wormald, M. R., Palma, A. S., Feizi, T., Harvey, D. J., Dwek, R. A., et al. (2010) · Glycobiology · doi:10.1093/glycob/cwq020 · Cited by 81
Self-citationEggink, D., Melchers, M., Wuhrer, M., van Montfort, T., Dey, A., Naaijkens, B. A., David, K. B., Douce, V. L., Deelder, A. M., Kang, K., et al. (2010) · Virology · doi:10.1016/j.virol.2010.02.019 · Cited by 77
Scanlan, C. N., Ritchie, G. E., Baruah, K., Crispin, M., Harvey, D. J., Singer, B. B., Lucka, L., Wormald, M. R., Wentworth, P., Zitzmann, N., et al. (2007) · Journal of Molecular Biology · doi:10.1016/j.jmb.2007.06.027 · Cited by 73
Self-citationDuenas-Decamp, M. J., Peters, P. J., Burton, D. R., & Clapham, P. R. (2008) · Journal of Virology · doi:10.1128/jvi.02585-07 · Cited by 66
Self-citationIacob, R. E., Perdivara, I., Przybylski, M., & Tomer, K. B. (2007) · Journal of the American Society for Mass Spectrometry · doi:10.1016/j.jasms.2007.11.022 · Cited by 65
Luallen, R. J., Lin, J., Fu, H., Cai, K. K., Agrawal-Gamse, C., Mboudjeka, I., Lee, F.-H., Montefiori, D. C., Smith, D. F., Doms, R. W., et al. (2008) · Journal of Virology · doi:10.1128/jvi.00412-08 · Cited by 65
Crispin, M., Harvey, D. J., Chang, V. T.-C., Yu, C., Aricescu, A. R., Jones, E. Y., Davis, S. J., Dwek, R. A., & Rudd, P. M. (2006) · Glycobiology · doi:10.1093/glycob/cwj119 · Cited by 63
Self-citationNeutralizing antibodies against HIV-1: can we elicit them with vaccines and how much do we need?
Montefiori, D. C., & Mascola, J. R. (2009) · Current Opinion in HIV and AIDS · doi:10.1097/coh.0b013e32832f4a4d · Cited by 61
Wolk, T., & Schreiber, M. (2006) · Medical Microbiology and Immunology · doi:10.1007/s00430-006-0016-z · Cited by 54
Crispin, M., Ritchie, G. E., Critchley, A. J., et al. (2004) · FEBS Letters · doi:10.1016/j.febslet.2004.04.045 · Cited by 50
Self-citationHIV sensitivity to neutralization is determined by target and virus producer cell properties
Mann, A. M., Rusert, P., Berlinger, L., Kuster, H., Günthard, H. F., & Trkola, A. (2009) · AIDS · doi:10.1097/qad.0b013e32832e9408 · Cited by 47
Luallen, R. J., Fu, H., Agrawal-Gamse, C., Mboudjeka, I., Huang, W., Lee, F.-H., Wang, L., Doms, R. W., & Geng, Y. (2009) · Journal of Virology · doi:10.1128/jvi.02537-08 · Cited by 35
Antigenic mimicry of the HIV envelope by AIDS-associated pathogens
Dunlop, D. C., Ulrich, A. K. C., Appelmelk, B. J., Burton, D. R., Dwek, R. A., Zitzmann, N., & Scanlan, C. N. (2008) · AIDS · doi:10.1097/qad.0b013e328314b5df · Cited by 30
Self-citationLuallen, R. J., Agrawal-Gamse, C., Hong-Tuo, F. U., Smith, D. F., Doms, R. W., & Geng, Y. (2009) · Glycobiology · doi:10.1093/glycob/cwp184 · Cited by 28
Protein-specific glycosylation: signal patches and cis-controlling peptidic elements
Hanisch, F., & Breloy, I. (2009) · Biological Chemistry · doi:10.1515/bc.2009.043 · Cited by 13
Antigenic Mimicry of the HIV Envelope by AIDS-Associated Pathogens
Dunlop, D. C., Ulrich, A. K. C., Dwek, R. A., Zitzmann, N., & Scanlan, C. N. (2008) · Web Science · Cited by 10
Self-citation
Cited by
Human milk oligosaccharides: Every baby needs a sugar mama
Bode, L. (2012) · Glycobiology · doi:10.1093/glycob/cws074 · Cited by 1,809
“While DC-SIGN binds to high-mannose type glycans on gp120 (Zhu et al. 2000; Doores et al. 2010), it has even higher affinities to Le blood group antigens (Naarding et al. 2005; van Liempt et al. 2006).”
BackgroundBeyond Shielding: The Roles of Glycans in the SARS-CoV-2 Spike Protein
Casalino, L., Gaieb, Z., Goldsmith, J. A., Hjorth, C. K., Dommer, A. C., Harbison, A. M., Fogarty, C. A., Barros, E. P., Taylor, B. C., McLellan, J. S., et al. (2020) · ACS Central Science · doi:10.1021/acscentsci.0c01056 · Cited by 947
Broadly Neutralizing Antibodies to HIV and Their Role in Vaccine Design
Burton, D. R., & Hangartner, L. (2016) · Annual Review of Immunology · doi:10.1146/annurev-immunol-041015-055515 · Cited by 583
Self-citationComplex-type N -glycan recognition by potent broadly neutralizing HIV antibodies
Mouquet, H., Scharf, L., Euler, Z., Liu, Y., Eden, C., Scheid, J. F., Halper-Stromberg, A., Gnanapragasam, P. N. P., Spencer, D. I. R., Seaman, M. S., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1217207109 · Cited by 550
Sialic acids in cancer biology and immunity
Pearce, O. M. T., & Läubli, H. (2016) · Glycobiology · doi:10.1093/glycob/cwv097 · Cited by 470
Metadata
- Authors
- Doores, K. J., Bonomelli, C., Harvey, D. J., Vasiljevic, S., Dwek, R. A., Burton, D. R., Crispin, M., & Scanlan, C. N.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2010-07-19
- Volume
- 107
- Issue
- 31
- Pages
- 13800-13805
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2096409198
- Cited by
- 329
- References
- 50
- FWCI
- 10.99
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.